On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

National University Cancer Institute, Singapore

InstitutionResearch output, impact & collaborations

National University Cancer Institute, Singapore is a institution indexed in ScholarIQ from OpenAlex.

What is known about National University Cancer Institute, Singapore?

ScholarIQrecord summary

National University Cancer Institute, Singapore is a research organisation in Singapore, SG. OpenAlex records 6,701 works and 847,408 citations for it. 1,537 researchers list it as their most recent affiliation.

How many works does National University Cancer Institute, Singapore have?

ScholarIQindexed works

National University Cancer Institute, Singapore has 6,701 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for National University Cancer Institute, Singapore →

How many citations does National University Cancer Institute, Singapore have?

ScholarIQcitation count

National University Cancer Institute, Singapore has 847,408 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for National University Cancer Institute, Singapore →

How many researchers are at National University Cancer Institute, Singapore?

ScholarIQresearcher count

National University Cancer Institute, Singapore has 1,537 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at National University Cancer Institute, Singapore?

ScholarIQavg h-index

National University Cancer Institute, Singapore has an average h-index of 69 in OpenAlex.

Open the OpenAlex record →

What is the ROR of National University Cancer Institute, Singapore?

ScholarIQror

The ROR for National University Cancer Institute, Singapore is on the source record.

Open the ROR →

What is the OpenAlex record for National University Cancer Institute, Singapore?

ScholarIQopenalex

The OpenAlex for National University Cancer Institute, Singapore is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind National University Cancer Institute, Singapore?

ScholarIQtop researchers by citations

Ross A. Soo · Lung Cancer Treatments and Mutations

686 works20,008 citations

What are the most-cited papers on National University Cancer Institute, Singapore?

ScholarIQmost cited works

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

Benjamin Solomon, Benjamin Besse, Todd M. Bauer, Enriqueta Felip, Ross A. Soo, D. Ross Camidge, Rita Chiari, Alessandra Bearz, Chia‐Chi Lin, Shirish M. Gadgeel, Gregory J. Riely, Eng Huat Tan, Takashi Seto, Leonard P. James, Jill S. Clancy, Antonello Abbattista, Jean-François Martini, Joseph Chen, Gerson Peltz, Holger Thurm, Sai‐Hong Ignatius Ou, Alice T. Shaw

The Lancet Oncology. 2018794 Citations

De-novo and acquired resistance to immune checkpoint targeting

Nicholas Syn, Michele W.L. Teng, Tony Mok, Ross A. Soo

The Lancet Oncology. 2017734 Citations

Isolation and retrieval of circulating tumor cells using centrifugal forces

Han Wei Hou, Majid Ebrahimi Warkiani, Bee Luan Khoo, Zirui Li, Ross A. Soo, Daniel Shao-Weng Tan, Wan‐Teck Lim, Jongyoon Han, Ali Asgar S. Bhagat, Chwee Teck Lim

Scientific Reports. 2013731 CitationsOPEN ACCESS

Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis

Wen Cai Zhang, Ng Shyh‐Chang, Yang He, Amit Rai, Shivshankar Umashankar, Siming Ma, Boon-Seng Soh, Li Sun, Bee Choo Tai, Min En Nga, Kishore Bhakoo, Senthil Raja Jayapal, Massimo Nichane, Qiang Yu, Dokeu A. Ahmed, Christie Tan, Wong Poo Sing, John Kit Chung Tam, Thirugananam Agasthian, Monireh Soroush Noghabi, Yin Huei Pang, Haw Siang Ang, Wayne Mitchell, Paul Robson, Philipp Kaldis, Ross A. Soo, Sanjay Swarup, Elaine Hsuen Lim, Bing Lim

Cell. 2012677 CitationsOPEN ACCESS

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

Robert M. Jotte, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodríguez‐Abreu, Maen Hussein, Ross A. Soo, Henry Jacob Conter, Toshiyuki Kozuki, Kuan-Chieh Huang, Vilma Graupner, Shawn W. Sun, Tien Hoang, Helen Jessop, Mark L. McCleland, Marcus Ballinger, Alan Sandler, Mark A. Socinski

Journal of Thoracic Oncology. 2020614 CitationsOPEN ACCESS

How much of the research on National University Cancer Institute, Singapore is open access?

ScholarIQopen access share

58%OPEN ACCESS

Gold

Green

Hybrid

25%

Bronze

17%

Closed

42%